Want to see HK:0557 full AI Analyst Report?
Top Page
China Tian Yuan Healthcare Group Limited
(0557)
Select Model
Select Model
Rating:47Neutral
Price Target:
HK$0.59
▼(-15.57% Downside)
Action:Reiterated
Date:06/27/26
The score is primarily held back by weak financial performance, especially steep revenue declines and sustained operating/net losses despite decent gross margins. Technicals are mixed with some intermediate support but weakness versus key shorter/longer moving averages and a potentially stretched stochastic reading. Valuation is penalized due to negative earnings (negative P/E) and no provided dividend yield.
Positive Factors
High gross margins
Sustained gross margins above ~50% indicate the core distribution business retains healthy unit economics and pricing power. This margin buffer is a durable strength: if revenue stabilizes, it can absorb SG&A and support a path to operating breakeven without requiring radical price changes.
Negative Factors
Sharp revenue contraction
A multi-year top-line decline (≈27% in 2025) erodes scale, reduces operating leverage, and weakens market position. Persistent revenue loss makes fixed-cost absorption harder and limits the ability to invest in distribution or customer retention, posing a durable headwind unless growth reverses.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Sustained gross margins above ~50% indicate the core distribution business retains healthy unit economics and pricing power. This margin buffer is a durable strength: if revenue stabilizes, it can absorb SG&A and support a path to operating breakeven without requiring radical price changes.
Read all positive factors
China Tian Yuan Healthcare Group Limited (0557) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$239.39M
Dividend YieldN/A
Average Volume (3M)3.33K
Price to Earnings (P/E)―
Beta (1Y)-0.75
Revenue Growth-28.56%
EPS Growth0.58%
CountryHK
Employees79
SectorFinancial
Sector Strength70
IndustryMedical - Distribution
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio14.08
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Tian Yuan Healthcare Group Limited Business Overview & Revenue Model
Company Description
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, the People's Republic of China, and Korea. It operates through Investment Holding, Healthcare, Money Lending and Related Bu...
How the Company Makes Money
null...
China Tian Yuan Healthcare Group Limited Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
58
Neutral
Cash Flow
55
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.18M | 26.84M | 45.23M | 54.22M | 94.59M |
| Gross Profit | 9.59M | 14.91M | 24.98M | 34.83M | 71.31M |
| EBITDA | -3.51M | -27.22M | -15.79M | -13.08M | -2.89M |
| Net Income | -34.01M | -34.24M | -15.48M | -29.04M | -16.85M |
Balance Sheet | |||||
| Total Assets | 224.98M | 260.93M | 302.95M | 333.55M | 376.40M |
| Cash, Cash Equivalents and Short-Term Investments | 29.51M | 27.05M | 26.73M | 31.60M | 77.89M |
| Total Debt | 38.72M | 45.97M | 45.91M | 51.13M | 59.66M |
| Total Liabilities | 88.36M | 84.98M | 87.77M | 91.52M | 92.35M |
| Stockholders Equity | 161.22M | 194.68M | 230.26M | 224.30M | 256.25M |
Cash Flow | |||||
| Free Cash Flow | 9.12M | 10.67M | 4.51M | -31.71M | 14.86M |
| Operating Cash Flow | 9.41M | 10.69M | 5.10M | -30.36M | 16.32M |
| Investing Cash Flow | -292.00K | -3.00K | 364.00K | -1.23M | -1.42M |
| Financing Cash Flow | -5.05M | -10.85M | -8.77M | -12.49M | -7.22M |
China Tian Yuan Healthcare Group Limited Technical Analysis
Negative
0.70
Price Trends
0.54
Positive
0.57
Positive
0.68
Negative
Market Momentum
0.02
Positive
49.86
Neutral
73.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0557, the sentiment is Negative. The current price of 0.7 is above the 20-day moving average (MA) of 0.64, above the 50-day MA of 0.54, and above the 200-day MA of 0.68, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 49.86 is Neutral, neither overbought nor oversold. The STOCH value of 73.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0557.
China Tian Yuan Healthcare Group Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$768.85M | 2.96 | 5.42% | 4.67% | -4.47% | 0.64% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$1.63B | 29.30 | 0.57% | 3.37% | 0.33% | -77.16% | |
66 Neutral | HK$590.51M | 73.33 | 0.19% | ― | 6.25% | ― | |
66 Neutral | HK$1.84B | 16.18 | 2.64% | 1.95% | -2.47% | 38.92% | |
47 Neutral | HK$239.39M | -3.82 | -33.69% | ― | -28.56% | 0.58% | |
41 Neutral | HK$341.54M | -0.27 | -29.62% | ― | 51.08% | 55.72% |
* Financial Sector Average
HK:0557
China Tian Yuan Healthcare Group Limited
0.60
-0.18
-23.08%
HK:0184
Keck Seng Investments (Hong Kong)
2.26
0.12
5.71%
HK:1270
Langham Hospitality Investments
0.46
-0.10
-17.27%
HK:0201
Magnificent Hotel Investments Limited
0.07
>-0.01
-5.71%
HK:1221
Sino Hotels (Holdings) Ltd.
1.54
0.17
12.00%
HK:0078
Regal Hotels International Holdings Limited
0.38
-0.27
-41.54%
China Tian Yuan Healthcare Group Limited Corporate Events
China Tian Yuan Healthcare to Sell Majority Stake in Subsidiary for RMB23 Million
Jun 9, 2026
China Tian Yuan Healthcare Group Limited has agreed to dispose of a 60.8077% equity stake in a subsidiary, referred to as the Target Company, held through its indirect wholly owned unit Hengqin Hanyuemei. The stake, representing registered capital...
China Tian Yuan Healthcare Moves to Re-elect Long-Serving Independent Director
May 29, 2026
China Tian Yuan Healthcare Group Limited has issued a supplemental announcement to its May 27, 2026 circular, clarifying arrangements for the re-election of long-serving independent non-executive director (INED) Mr. Yuen Kwok Kuen at its upcoming ...
China Tian Yuan Healthcare Calls 2026 AGM, Seeks Fresh Share Issue Mandate
May 27, 2026
China Tian Yuan Healthcare Group Limited has called its thirty-seventh annual general meeting for 29 June 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements for the year ended 31 December 2025 and the r...
China Tian Yuan Healthcare Unit Signs 2026 Connected Services Deal With Parent
Apr 20, 2026
China Tian Yuan Healthcare Group’s indirect non-wholly owned subsidiary Deshang Clinic has entered into a 2026 Service Framework Agreement with ultimate holding company Ningxia Tianyuan, under which it will provide occupational health examin...
China Tian Yuan Healthcare Posts Another Annual Loss on Lower Revenue and Goodwill Impairment
Mar 30, 2026
China Tian Yuan Healthcare Group Limited, a Hong Kong-listed healthcare group incorporated in the Cayman Islands, reported audited consolidated results for the year ended 31 December 2025. The company’s activities span healthcare operations ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.